JACOBS LEVY EQUITY MANAGEMENT, INC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 153 filers reported holding ITEOS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,033,846
-22.5%
459,712
-6.3%
0.03%
-18.9%
Q2 2023$6,492,631
-7.4%
490,380
-4.8%
0.04%
-14.0%
Q1 2023$7,008,129
-28.7%
514,925
+2.3%
0.04%
-35.8%
Q4 2022$9,833,941
+10.7%
503,530
+8.0%
0.07%
-4.3%
Q3 2022$8,883,000
+468.7%
466,325
+860.6%
0.07%
+536.4%
Q1 2022$1,562,000
-26.4%
48,545
+6.6%
0.01%
-21.4%
Q4 2021$2,121,000
+215.6%
45,551
+73.8%
0.01%
+180.0%
Q2 2021$672,00026,2050.01%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders